Flore (FKA Sun Genomics)
Microbiome health company curing dysbiosis through precision probiotics
Flore (FKA Sun Genomics) is active in the consumer bio space based in United States, founded in 2016.
Profile
Flore is a microbiome health company focused on curing dysbiosis through personalized probiotics. Our platform enables the highest resolution profiling of customer gut makeup, empowering them to make and track changes over time.
Its activity falls under consumer bio; the profile below is assembled from public directory data.
United States is where the company is located.
Directory data places it at the SOSV portfolio company stage.
Its team size is recorded as 11-50 employees.
It has disclosed roughly $1.1M in funding.
| Sector | Consumer Bio |
|---|---|
| Country | United States |
| Founded | 2016 |
| Employees | 11-50 |
| Stage | SOSV portfolio company |
| Total funding | $1,120,000 |
Website: flore.com
Sign in to view the contact information we hold for Flore (FKA Sun Genomics).
Create a free account
Create a free account